Search - tctmd.com

Displaying 81 - 100 of 125

Sort: Relevancy | Date

Presentation ACC 2013

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Presenter: Ian T. Meredith

March 09, 2013

News Conference News ACC 2013

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

L.A. McKeown

March 09, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

News Daily News

EES Noninferior to SES for Treating Total Coronary Occlusions

Jason Kahn

February 25, 2013

News Industry News

Vascular Solutions Introduces the Quattro Elite Snare

February 13, 2013

News Industry News

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

February 11, 2013

Presentation TCT 2013

Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent versus Cobalt Chromium Everolimus-Eluting Stent

Presenter: Ruogu Li, Adrian Low, Chi Hang Lee, Mark Chan, Swee Guan Teo, Koo Hui Chan, Mark Richards Arthur, Huay Cheem Tan

January 31, 2013

News Daily News

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

December 05, 2012

News Conference News TCT 2012

Registries Show Low Complication Rates With New Heart Valves

October 23, 2012

News Conference News TCT 2012

New Results from SYNTAX, SPIRIT Trials Presented

October 22, 2012

News Conference News TCT 2012

Meta-Analyses Show Improved Outcomes with DES vs. BMS

October 22, 2012

News Daily News

Stent Fractures Persist Among Newer-Generation Devices

Jason Kahn

October 02, 2012

News Daily News

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

September 19, 2012

News Industry News

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

August 07, 2012

News Daily News

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

Leah Lawrence

June 15, 2012

News Conference News EuroPCR 2012

TAVR Studies Tease Out Influences on Clinical Outcome

Caitlin E. Cox

May 18, 2012

News Conference News EuroPCR 2012

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Caitlin E. Cox

May 17, 2012

News Industry News

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

April 09, 2012

Presentation ACC 2012

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Presenter: Gregg Stone

March 28, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

Advertisement

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

PARTNER II Cohort B Demonstrates Safety, Efficacy of Lower Profile TAVR Device

Pair of Studies Show Positive Stent Results at ACC

EES Noninferior to SES for Treating Total Coronary Occlusions

Vascular Solutions Introduces the Quattro Elite Snare

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval

Real-World Comparison of Clinical Outcomes of Patients who Received New Generation Platinum Chromium Everolimus-Eluting Stent versus Cobalt Chromium Everolimus-Eluting Stent

Registry Study Defines Proper Role for Embolization Device for Intracranial Aneurysm

Registries Show Low Complication Rates With New Heart Valves

New Results from SYNTAX, SPIRIT Trials Presented

Meta-Analyses Show Improved Outcomes with DES vs. BMS

Stent Fractures Persist Among Newer-Generation Devices

Korean Registry Confirms Edge of Everolimus- Over Zotarolimus-Eluting Stents

Abbott's Omnilink Elite® Vascular Balloon-Expandable Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Meta-analysis: Less Stent Thrombosis at 2 Years with EES vs. Other DES

TAVR Studies Tease Out Influences on Clinical Outcome

Trials Take on Permanent- vs. Biodegradable-Polymer Technology

Abbott Receives Approval for Next-Generation XIENCE PRIME™ Drug Eluting Stent in Japan

Two-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents in De Novo Coronary Artery Lesions

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content